Specialized junctional sites that connect the plasma membrane (PM) and endoplasmic reticulum (ER) play critical roles in controlling lipid metabolism and Ca 2+ signalling [1] [2] [3] [4] . Store-operated Ca 2+ entry mediated by dynamic STIM1-ORAI1 coupling represents a classical molecular event occurring at ER-PM junctions, but the protein composition and how previously unrecognized protein regulators facilitate this process remain ill-defined. Using a combination of spatially restricted biotin labelling in situ coupled with mass spectrometry 5, 6 and a secondary screen based on bimolecular fluorescence complementation 7 , we mapped the proteome of intact ER-PM junctions in living cells without disrupting their architectural integrity. Our approaches led to the discovery of an ER-resident multi-transmembrane protein that we call STIMATE (STIM-activating enhancer, encoded by TMEM110) as a positive regulator of Ca 2+ influx in vertebrates. STIMATE physically interacts with STIM1 to promote STIM1 conformational switch. Genetic depletion of STIMATE substantially reduces STIM1 puncta formation at ER-PM junctions and suppresses the Ca 2+ -NFAT signalling. Our findings enable further genetic studies to elucidate the function of STIMATE in normal physiology and disease, and set the stage to uncover more uncharted functions of hitherto underexplored ER-PM junctions.
ER-PM junctions are defined as spatially extended or small circular compartments in which the PM and ER membranes are stably separated at a distance of approximately 10-20 nm without direct membrane fusion 1 . The broad significance of this structure has only recently begun to be appreciated, with emerging roles in lipid metabolism and Ca 2+ homeostasis [1] [2] [3] [4] . Although ER-PM junctions were first observed over half a century ago 8 , systematic dissection of this specialized subcompartment at the molecular level remains challenging owing to the lack of appropriate methods and convenient tools, which motivated us to explore a non-biased yet effective approach to obtain an integrated picture of ER-PM junctions. By taking advantage of an in situ protein labelling technique 5, 6 , we set out to map the proteome of ER-PM junctions that are dedicated to storeoperated calcium entry (SOCE), a fundamental physiological process that is mediated by two protein families, STIM and ORAI (ref. 3) . The ER-resident Ca 2+ sensor protein STIM1, when fused to an engineered ascorbate peroxidase 2 (APEX2), enables proximity biotin labelling with least perturbation to the architecture of ER-PM junctions, thereby opening new avenues for capturing protein complexes situated at or in close proximity of STIM1 in living cells (Fig. 1a) . At the heart of this in situ protein labelling technique is APEX2-catalysed conversion of biotin-phenol in the presence of H 2 O 2 to phenoxyl radicals, which could attack electron-rich amino acids and covalently attach biotin tags to targeted proteins 5, 6 . Biotinylated proteins can be subsequently enriched by streptavidin beads and analysed by mass spectrometry. Notably, these radicals have very short lifetimes (<1 ms) with an estimated labelling radius of <20 nm (refs 5,9,10) , thus matching the distance that separates ER and PM at junctional sites. One additional benefit of this approach is that it enables dynamic sampling of this specialized cellular compartment during the translocation of STIM1 from ER towards PM, thereby allowing us to compare protein complexes surrounding STIM1 before and after store depletion.
Following ER Ca 2+ depletion elicited by thapsigargin, a blocker of the sarco/endoplasmic reticulum Ca 2+ ATPase (SERCA), total internal reflection fluorescence (TIRF) microscope imaging showed interactors at ER-PM junctions through APEX2-mediated biotin labelling in situ. APEX2 fused to STIM1 enables biotin labelling on proteins located <20 nm from STIM1. This reaction requires externally added H 2 O 2 . Biotinylated proteins were further affinity-enriched with streptavidin beads, with the eluted products analysed by mass spectrometry (MS). (b) Fluorescence imaging of biotinylated proteins (stained with streptavidin conjugated with Dylight594) in HEK293 cells expressing GFP-STIM1-APEX2 as illustrated in a. Store depletion was induced by 1 µM thapsigargin (TG) in nominally Ca 2+ -and serum-free medium. Scale bar, 5 µm. (c) Silver staining and immunoblotting of biotinylated protein complexes surrounding STIM1 puncta at ER-PM junctions. Shown on the SDS-PAGE are samples before (lanes 1-3) and after (lanes 4-6) streptavidin bead enrichment, as well as the eluted samples immunoblotted by streptavidin conjugated by horseradish peroxidase (streptavidin-HRP, lanes 7-9). (d) Scatter plot of identified potential STIM1-binding partners. BiFc ( Supplementary Fig. 1a-c) was used as a secondary assay to confirm strong hits that emerged from the proteomic study. The amino-terminal fragment of YFP (YFP N , residues 1-155) is fused to the STIM1 C terminus as the bait to interact with prey in a customized library containing candidate genes fused with the C-terminal half of YFP (YFP C , residues 156-238). Each candidate was plotted according to its MS spectral counts (Y axis) and the degree of YFP fluorescence restoration (X axis, as shown in Supplementary Fig. 1c) . (e) Thapsigargin-induced Ca 2+ influx in HEK293 cells transfected with control siRNA (n = 30), STIMATE siRNA oligonucleotide 1 (n = 34), STIMATE siRNA oligonucleotide 2 (n = 45) or STIM1 siRNA (n = 60 cells pooled across three independent experiments). Error bars denote s.e.m. (f) Quantification of NFAT-dependent luciferase activity in HEK293 cells treated with the indicated siRNA oligonucleotides or co-transfected with an siRNA-resistant STIMATE construct (siR-STIMATE). * * P < 0.01; * * * P < 0.001 (paired Student's t-test). Error bars denote s.d. for n = 12 wells of cultured cells (0.1-0.5 million cells per well) pooled across three independent experiments. Unprocessed original scans of blots/gels are shown in Supplementary Fig. 6 .
that EGFP-tagged STIM1-APEX2 formed puncta and co-localized tightly with biotinylated proteins, the latter of which were labelled by fluorophore-conjugated streptavidin (Fig. 1b) . This process was dependent on H 2 O 2 because biotinylation was not observed when omitting H 2 O 2 in the reaction medium. The H 2 O 2 -and APEX2-dependent biotinylation of protein complexes surrounding STIM1 was further confirmed by silver staining after affinity enrichment and independently by western blotting probed by streptavidin-HRP (Fig. 1c) . As ORAI1 (relative molecular mass, 33,000 (M r 33K)) is a known binding partner of STIM1, we first analysed a gel slice corresponding to M r 25K-37K on the SDS-PAGE with mass spectrometry in our initial experiment and confirmed the presence of ORAI1 using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). In the same gel band, we repeatedly detected the gene product of TMEM110 (RefSeq ID: NM_198563), hereafter designated as STIMATE (for STIM-activating enhancer, Supplementary Fig. 1 ). In our subsequent LC-MS/MS analyses on all of the eluted products, we further identified a total of 73 potential STIM1 interactors, with 17 detected in both store-full and storedepleted HEK293 cells (Supplementary Tables 1 and 2 ). Most of them fell into the categories of ER-or PM-resident proteins, cytoskeletal components, and proteins functioning in intracellular membrane trafficking or post-translational modifications. Notably, 18% of them also appeared as strong hits identified in an independent genomewide screen for regulators of nuclear factor of activated T-cells (NFAT; ref. 11), a transcriptional factor that is downstream of Ca 2+ influx mediated by STIM-ORAI signalling. The prowess of this approach was further attested by the identification of EB1, SERCA2, ORAI1, voltage-dependent Ca 2+ channels, extended synaptotagmin 1 and septins as candidate proteins that are in close proximity to STIM1 (Supplementary Tables 1 and 2 ). These proteins are known to either directly interact with STIM1 or reside in the ER-PM junctions 3, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Given the major interest in identifying protein regulators at ER-PM junctions that are directly involved in STIM1-dependent Ca 2+ influx, we created a customized prey library of 38 genes representing most gene products (for example, STIMATE) identified under both store-full (resting) and store-depleted conditions, as well as candidate genes that have an annotated function in Ca 2+ signalling or harbour predicted transmembrane domains (Supplementary  Table 3 ). A secondary screen based on bimolecular fluorescence complementation (BiFc, Supplementary Fig. 1a-c ) was performed to examine their potentials as STIM1 interactors either before or after thapsigargin-induced store depletion. Our assay is based on the reconstitution of an intact yellow fluorescent protein (YFP) from two complementary non-fluorescent fragments when they are brought together through STIM1 and STIM1-binding partners. Again, STIMATE stood out as one of the strongest hits in the screen ( Fig. 1d and Supplementary Fig. 1b,c) . Taken together, STIMATE, a positive regulator of NFAT activation identified in a previous genome-wide RNAi screening 11 , emerged early and prominently in both screens, which prompted us to further examine its role in modulating Ca 2+ flux at ER-PM junctions, and in parallel, to dissect the molecular mechanism underlying its interplay with STIM1.
To examine the effect of STIMATE on SOCE and its downstream effectors, we monitored the Ca 2+ flux and NFAT-dependent activities by treating HEK293 cells with siRNA oligonucleotides designed to specifically target STIMATE. The knockdown efficiency (∼60-80%) of two synthesized STIMATE siRNA oligonucleotides was confirmed by quantitative PCR (Supplementary Fig. 2 ). As shown in Fig. 1e ,f, thapsigargin-triggered SOCE, as well as NFAT-dependent luciferase activity, was significantly suppressed in HEK293 cells transfected with either of the two STIMATE siRNA oligonucleotides. The inhibitory effect could be rescued in STIMATE-siRNA-treated cells by overexpression of an siRNA-resistant variant of STIMATE (Fig. 1f) .
To further demonstrate the role of STIMATE in modulating SOCE, we generated STIMATE knockout (STIMATE-KO) HEK293 stable cell lines by disrupting exon 4 of human STIMATE with the CRISPR/Cas9 genome-editing tool 22 . Gene disruption was validated using both the Surveyor nuclease assay and Sanger's sequencing of exon 4 ( Supplementary Fig. 2c,d ). In two stable STIMATE-KO clones harbouring early stop codons, the cytoplasmic Ca 2+ increase in response to ionomycin-induced store depletion ( Supplementary  Fig. 2e ) was profoundly reduced, whereas the Ca 2+ release from the ER Ca 2+ store remained largely unaltered (first peak, Supplementary  Fig. 2e ). Together, these results suggest that STIMATE is a previously unrecognized positive modulator of SOCE.
STIMATE is broadly expressed in mouse and human tissues ( Supplementary Fig. 2a ). The STIMATE protein is predicted to contain multiple putative transmembrane segments with a polybasic C-tail ( Fig. 2a and Supplementary Fig. 1d ), but its subcellular localization and membrane topology remain unknown. When overexpressed in HEK293, HeLa or COS-7 cells, STIMATE localized to ER and overlapped tightly with the ER marker Sec61β (ref. 23) or DsRed-ER ( Fig. 2b and Supplementary Fig. 3 ). Interestingly, STIMATE exhibited a predominant PM-like localization with a small pool trapped intracellularly when the last 74 amino acids were truncated (STIMATE , Fig. 2a) . Through a serial truncation study combined with site-directed mutagenesis, we further mapped a region (residues 241 KXRXRR 246 ) that seems to be critical for keeping STIMATE localized within the ER. Substitution of these positively charged residues with glutamines (K or R>Q mutant) caused a large fraction of the ER-resident STIMATE 1-250 -mCherry to exhibit a PM-like distribution (Fig. 2a) . Next, we performed a chemical crosslinking experiment to examine the oligomeric state of STIMATE. As shown in Fig. 2c , addition of the membrane-permeable crosslinker DSS resulted in the appearance of protein bands corresponding to multimers of STIMATE on SDS-PAGE, suggesting that STIMATE could be assembled as oligomers in ER membrane. This result echoes the presence of a GXXXG transmembrane association motif 24 in one of its predicted transmembrane segments ( Supplementary Fig. 1d ). The tendency of STIMATE to multimerize was further attested by the efficient restoration of YFP fluorescence when STIMATE was carboxy-terminally tagged with two complementary non-fluorescent YFP fragments in the BiFc assay ( Supplementary Fig. 1b,c) . The membrane topology of STIMATE was further determined by using a fluorescence protease protection assay 25 with EGFP-STIM1 and STIM1-YFP as controls. We found that both termini of STIMATE face towards the cytosolic side of ER ( Supplementary Fig. 1e-h ).
We next examined whether STIMATE is located in the vicinity of the two main players of SOCE, STIM1 and ORAI1. When expressed together with ORAI1 or STIM1 in HEK293 cells, STIMATE colocalized tightly with STIM1 to ER but not with ORAI1 at resting conditions (Fig. 2d) , a finding that is further corroborated by results from an independent fluorescence resonance energy transfer (FRET) assay (Fig. 2e) . Discernible FRET signals were detected only in HEK293 cells co-transfected with CFP-STIMATE and STIM1-YFP but not in cells coexpressing CFP-STIMATE and ORAI1-YFP (Fig. 2e) . When expressed alone or coexpressed with an ER marker in HEK293, HeLa or COS-7 cells, STIMATE did not seem to globally translocate to ER-PM junctions as STIM1 did after store depletion ( Fig. 2f , Supplementary Fig. 3 and Supplementary Fig. 4a ). However, when STIMATE was coexpressed with STIM1 in the same cell, we observed the co-localization of STIMATE with STIM1 at ER-PM junctions in a fraction of cells after store depletion. This phenomenon was less obvious under the confocal microscope but more pronounced when cells were examined by TIRF microscopy, which reports exclusively on fluorescence within 200 nm above the coverslip ( Fig. 2g and Supplementary Fig. 4b ). The coexpression of ORAI1 did not seem to increase the degree or tendency of STIMATE to co-localize with STIM1 ( Supplementary Fig. 4c,d ). Thus, a portion of STIMATE might translocate to ER-PM junctions in a STIM1-dependent manner in store-depleted cells. Together, our data imply that STIMATE co-localizes with STIM1 within the ER and might also reside in close proximity to STIM1 at ER-PM junctions in response to store depletion in mammalian cells. After expression of mCherry-STIMATE in HEK293 cells cotransfected with STIM1, we frequently observed the spontaneous formation of STIM1 puncta even when the ER store was not depleted ( Fig. 2g and Supplementary Fig. 4b ,c). This scenario was most prominently visualized in cells stably expressing both ORAI1-CFP and STIM1-YFP ( Fig. 3a-c) . STIM1 puncta could be readily detected in cells transfected with mCherry-STIMATE before store The segment inside the rectangle shows the median, whereas the whiskers above and below the box mark the minimum and maximum. * * * P < 0.001 (n = 15 cells pooled across three independent experiments; paired Student's t-test). depletion. In contrast, the other cells in the same field without STIMATE overexpression showed an even distribution of STIM1 at the footprint of HEK293 cells (Fig. 3a) . On store depletion, STIMATE-expressing cells formed significantly larger STIM1 puncta (Fig. 3b) . Consistent with the pre-formation of STIM1 puncta before store depletion, overexpression of mCherry-STIMATE also elicited constitutive Ca 2+ influx in these stably expressing cells when we switched the extracellular Ca 2+ concentration from 0 to 1 mM (Fig. 3c) . The Ca 2+ flux could be reversed by withdrawing Ca 2+ or by adding 2-APB, a pharmacological tool that is widely used at high concentrations (∼50-100 µM) to block SOCE.
These findings led us to propose that STIMATE could modulate STIM1 puncta formation at ER-PM junctions. Indeed, genetic disruption of STIMATE in HEK293 (STIMATE-KO) cells induced a substantial reduction in the amounts of STIM1 puncta at ER-PM junctions ( Fig. 3d and Supplementary Video 1) . Compared with thapsigarginstimulated normal HEK293 cells, the fluorescence intensity of EGFP-STIM1 at the TIRF layer of STIMATE-KO cells dropped by almost 70%. STIMATE knockout appreciably delayed the formation of STIM1 puncta, and resulted in a significant reduction in the puncta size at ER-PM junctions (Fig. 3e ). An appreciable (∼10-15%), but less pronounced, reduction in puncta formation was also observed in STIMATE-KO cells expressing the STIM1 gain-of-function mutants D76A and L258G ( Supplementary Fig. 5a-d) . Subsequent scrutiny under high-resolution electron microscopy further revealed that fewer STIM1 proteins migrated into cortical ER (cER, Fig. 3f and Supplementary Fig. 5e ), a specialized ER network that lies immediately beneath the PM (<20 ∼ 30 nm). In aggregate, these results indicate that STIMATE is required to promote efficient STIM1 clustering at ER-PM junctions, which might be achieved through modulating cER accumulation or modulating STIM1 activation as described below.
To examine the effect of STIMATE depletion on cER, we compared the cER accumulation in native and STIMATE-KO HEK293 cells. We used the genetically encoded fluorescent cER marker, MAPPER (membrane-attached peripheral ER), as readout because it has been recently shown to selectively label cER and co-localize tightly with activated STIM1 puncta at ER-PM junctions 20 . We noted that depletion of STIMATE caused approximately 8-10% decrease in the intensity or density of cER in HEK293 cells ( Supplementary Fig. 5f-h ). To rule out the possibility that the constitutive localization of MAPPER at ER-PM junctions might cause bias in our analysis on cER, we created an optogenetic tool, LiMETER (light-inducible membrane-tethered peripheral ER, Fig. 4 derived from Avena sativa phototropin 1 (refs 26,27) , followed by a Cterminal PM-targeting polybasic tail isolated from the small G protein Rit 28 ( Fig. 4a) . In the dark, the Jα helix docks to the LOV2 domain and cages the polybasic tail to prevent its interaction with negatively charged PM-resident phosphoinositides. On blue light stimulation, photoexcitation generates a covalent adduct between a cysteine residue (Cys 450) and the flavin cofactor in LOV2, and subsequently promotes the undocking and unwinding of the Jα helix 26, 27 , thereby exposing the Rit polybasic C-tail to enable translocation of the protein towards PM to form puncta-like structures 28 . As a result, LiMETER underwent photo-inducible accumulation at ER-PM junctions to specifically label cER (Fig. 4 and Supplementary Video 2) . Notably, this process can be reversibly repeated with multiple light-dark cycles without significant loss in the magnitude of response (Fig. 4d) . This unique tool enables us to quantitatively examine the effect of STIMATE depletion on the dynamics of cER accumulation at defined spatiotemporal resolution. When compared with native HEK293 cells, we observed 10-12% decrease in the rate and extent of LiMETER accumulation at ER-PM junctions in STIMATE-KO HEK293 cells after blue light illumination (Fig. 4c,d) . Thus, by using either MAPPER or LiME-TER as a cER marker, we found that genetic depletion of STIMATE noticeably affects cER accumulation in HEK293 cells. Nonetheless, the ∼10% decrease in the efficiency of cER accumulation could not fully explain the more pronounced effect (∼70%) on STIM1 puncta formation in STIMATE-depleted cells (Fig. 3d,e) . This prompted us to further explore alternative mechanisms by focusing on the initial activation steps of STIM1.
Results from both the BiFc ( Supplementary Fig. 1a -c) and FRET (Fig. 2e) assays suggest a possible interaction between STIMATE and STIM1 in HEK293 cells. We further confirmed this by using coimmunoprecipitation (Fig. 5a ). To investigate how STIMATE modulates STIM1 actions, we applied a combination of coimmunoprecipitation (Fig. 5b) and FRET (Fig. 5c ) methods to map the domain(s) within STIM1 that mediate its interaction with STIMATE. We narrowed down the minimal STIMATE-interacting domain to the juxtamembrane coiled coil region of STIM1 (STIM1-CC1, residues 233-343). In both assays, the minimal ORAI-activating domain of STIM1 (CAD/SOAR; refs 29,30) showed negligible or no discernible interaction with STIMATE. As the longest cytosolic fragment of STIMATE protein is its C-terminal region (STIMATE-CT, residues 214-294, Fig. 2a and Supplementary Fig. 1d ), we further expressed STIMATE-CT in bacteria and purified the recombinant protein to examine whether it would directly interact with STIM1 cytosolic domains. GST-tagged STIMATE-CT immobilized on GS4B resin was able to pull down both the entire STIM1 cytoplasmic domain (233-685) and STIM1-CC1 (Fig. 5d) . The dissociation constant of the interaction between STIMATE-CT and STIM1-CC1 was further determined to be 8.9 ± 0.7 µM (Fig. 5e) . Overall, these studies clearly demonstrated a direct physical contact between STIMATE and STIM1 in vitro.
After store depletion, STIM1 is activated through a conformational switch mechanism by undocking CAD/SOAR from CC1, thus projecting CAD/SOAR towards the PM to engage and gate ORAI1 channels 31 . The observation of a direct interaction between STIMATE-CT and STIM1-CC1 raised the possibility that STIMATE might promote STIM1 conformational switch through disrupting the intramolecular trapping mediated by CC1-SOAR association 32 . To test this, we developed a two-component FRET assay by fusing CFP or YFP to STIM1 and SOAR, respectively. This assay enabled us to monitor CC1-SOAR interaction in real time, and more importantly, to examine the effect of STIMATE on the STIM1 conformational switch in living cells 32 . Under resting conditions, YFP-SOAR was tightly docked towards the ER-resident STIM1 and showed a high resting FRET signal (Fig. 5f) . On ionomycin stimulation, YFP-SOAR undocked from CC1 and thus caused a profound decrease of the FRET signal. The coexpression of STIMATE in this assay significantly reduced the resting FRET signal (Fig. 5f ), implying that STIMATE could at least partially release STIM1 autoinhibition possibly by weakening CC1-SOAR association at rest. STIMATE-CT exhibited a similar effect but was much less potent, probably because this process requires anchoring of the STIMATE C-tail in the vicinity of the ER membrane or it involves coordinated actions of the C-tail with other regions of STIMATE. The consequence of STIMATE-mediated action on STIM1 was further reflected in enhanced FRET signals between CFP-STIM1 and YFP-STIM1 (Fig. 5g) or STIM1-YFP and ORAI1-CFP at rest (Fig. 5h) , and culminated in constitutive Ca 2+ influx (Fig. 3c) . Clearly, our data provide compelling evidence to support a model in which STIMATE interacts with the juxtamembrane CC1 region of STIM1 to perturb the CC1-SOAR association that is the basis for STIM1 autoinhibition 32 , thereby shifting the equilibrium towards activated states to promote the conformational switch and subsequent translocation of STIM1 towards ER-PM junctions.
In summary, we have applied a non-disruptive biotin labelling approach to capture protein complexes in close proximity to STIM1 at ER-PM junctions in living cells. Our findings not only afford an initial view on the protein composition of intact ER-PM junctions under physiological conditions, but also provide a framework for future dissection of their roles in cellular signalling, human health and disease. In particular, our study has established an irreplaceable role of the previously unrecognized ER-resident protein STIMATE in modulating STIM1-dependent Ca 2+ signalling at ER-PM junctions. Major questions that warrant further investigation include: how STIMATE choreographs with other components at ER-PM junctions to coordinate Ca 2+ signalling and other cellular events; and how STIMATE itself contributes to the formation and maintenance of ER-PM junctions.
METHODS
Methods and any associated references are available in the online version of the paper. Antibodies. Streptavidin-DyLight594 (catalogue no. 21842, 1:2,000 for immunofluorescence staining) and streptavidin-HRP (N100, 1:4,000 for western blotting (WB)) were purchased from Thermo Scientific. Mouse monoclonal anti-FLAG antibody (clone number M2, catalogue no. F3165, 1:3,000 WB, 1.25 µg per 100 µg of total protein for immunoprecipitation (IP)) was purchased from Sigma. The rabbit polyclonal anti-GFP antibody (sc-8334, 1:1,000 WB, 0.5 µg per 100 µg of total protein for IP) was obtained from Santa Cruz Biotechnology. The mouse monoclonal and rabbit polyclonal anti-mCherry antibodies were obtained from Clontech (clone number 1C51, catalogue no. 632543, 1:1,000 WB) and Novus Biologicals (NBP2-25157, 1:2,000 WB), respectively. Mouse anti-rabbit IgG conformation specific (L27A9)-HRP (5127s, 1:2,000) antibody was obtained from Cell Signaling and used in IP experiments. Secondary antibodies, including goat anti-mouse IgG-HRP (sc-2005, 1:2,000) and goat anti-rabbit IgG-HRP (sc-2004, 1:2,000), were purchased from Santa Cruz Biotechnology.
Cell lines. Cell lines including HEK293 (CRL-1573), HeLa (CCL-2) and COS-7
(CRL-1651) were purchased from American Type Culture Collection (ATCC). The cell lines were validated by short tandem repeat profiling analysis by ATCC. Cells stably expressing STIM1, ORAI1 or STIM1-ORAI1 were subsequently generated on the basis of the aforementioned cell lines after geneticin or puromycin selection. All of the cell lines were free of mycoplasma contamination.
Plasmids. The cDNA clone encoding human STIMATE was purchased from DNASU Plasmid Repository. GFP-STIMATE, STIMATE-GFP and FLAG-STIMATE were generated through gateway cloning by using the vectors pCDNA-DEST54, pCDNA-DEST47 (Life Technologies), and a customized FLAG-tagged destination vector. STIMATE-YFP and STIMATE-CFP was made by inserting STIMATE between NheI-BamHI sites of pEYPF-N1 or pECFP-N1 (ClonTech). mCherry-STIMATE or CFP-STIMATE was made by inserting amplified fragments into the pCDNA3.1(+) vector. mCherry-tagged STIMATE truncation variants were made by ligation into pmCherry-N1 between NheI-BamHI sites. STIMATE mutant constructs were subsequently made by using the QuikChange Lightning Multi site-directed mutagenesis kit (Agilent). Full-length cDNA of human STIM1 was subcloned into pCMV6-XL5 (Origene) 33 with the insertion of EGFP or YFP between two additional NarI sites introduced immediately after residue Asn 38. For STIM1-YFP constructs, human STIM1 was inserted into pEYFP-N1 between XhoI and BamHI. pCDNA3.1(+)-mCherry-ORAI1 was made by sequential insertion of mCherry and human ORAI1. The ER labelling plasmid pDsRed2-ER was obtained from Clontech. mCherry-Sec61β, mCherry-STIM1 (ref. 29 for in situ biotinylation, we replaced the mitochondria-targeting sequence with EGFP-STIM1 between the AflII-BamHI sites of pCDNA3-mito-APEX (Addgene: 42607) and further introduced the mutation A134P into the soybean APEX to enhance its enzymatic activity 5, 6 . All of the constructs were confirmed by both DNA sequencing and diagnostic digestion.
Human STIM1-YFP N was generated from pDONR221-STIM1 (DNASU) and pBabe-CMV-YFP N DEST-neo 34 through Gateway cloning (Life Technologies). The prey library was generated by mixing pBabe-CMV-YFP C -DEST-puro with Entry clones encoding selected candidate genes (obtained from DNASU, Supplementary Table 3 ) through Gateway cloning. To generate LiMETER, a human codon-optimized gBlock gene fragment was synthesized (Integrated DNA Technologies) based on the scaffold of MAPPERs (ref. 20) and cloned into pcDNA3.1(+) between NheI and XbaI sites, followed by replacing FRB with LOV2.
The sequences of STIM1 cytoplasmic fragments were amplified by PCR and cloned into the pProEX HTb vector (Life Technologies) between the BamHI and XhoI sites for expression as (His) 6 -tagged proteins 31, 35 . The STIMATE C-terminal domain (STIMATE-CT residues 214-294) was constructed as a fusion protein with the B1 domain of streptococcal protein G (GB1) for increased solubility or with glutathione S-transferase (GST) for pulldown assays. For the construct GB1-STIMATE-CT, we sequentially inserted GB1 at NcoI-BamHI sites and STIMATE-CT at BamHI-XhoI sites of the pProEx HTb vector. For the construct GST-STIMATE-CT, the gene was inserted into the pGEX-6P-1 vector at BamHI-EcoRI sites.
sgRNA-directed knockout of STIMATE using the CRISPR/Cas9 genomeediting tool. sgRNA targeting the sequence 5 -GGCATGCTGCTCATCTACGT GGGG-3 (underscored, protospacer adjacent motif or PAM) on exon 4 of human TMEM110 was designed with the online tool (http://crispr.mit.edu; ref. 22 ) and inserted into the BbsI site of the pSpCas9(BB)-2A-Puro vector (Addgene catalogue no. 48139) to generate px459-sgTMEM110. The sgRNA-containing plasmids were transfected into HEK293 cells and subjected to puromycin selection (2 µg ml −1 ) for 2-4 days. Survival clones were then seeded into 96-well plates and later expanded to 24-well plates for maintenance in the presence of 1 µg ml −1 puromycin. The gene disruption was first confirmed by Surveyor nuclease assay (see below, Supplementary  Fig. 2c ) and ultimately validated by Sanger's sequencing (Supplementary Fig. 2d ).
Surveyor nuclease assay for detection of genome modifications. Single colonies stably expressing px459-sgTMEM110 were picked up by using a limitingdilution assay. Genomic DNA from control (transfected with empty pX459 vector) or STIMATE-KO stable cell clones was extracted using the Quick-gDNA Kit (Zymo Research). The genomic region flanking the CRISPR/Cas9 targeting site for TMEM110 was PCR amplified by using the primers listed in Supplementary  Table 4 . The PCR products were purified using the Gel DNA Recovery Kit (Zymo Research) according to the manufacturer's instructions. Purified PCR products from control and stable cells were mixed and subjected to a reannealing process to produce heteroduplex formation by following the procedures described in the SURVEYOR Mutation Detection Kit (Transgenomic). After reannealing, products were treated with SURVEYOR nuclease and enhancer S (Transgenomic). The digested products were then subjected to electrophoresis on a 2% agarose gel and visualized with SYBR gold (Life Technologies) staining.
Quantitative real-time polymerase chain reaction (qPCR) analysis on STIMATE distribution. Total RNA was isolated from cells or tissues, and firststrand cDNA was generated from total RNA using oligo-dT primers and reverse transcriptase II (Life Technologies). Real-time qPCR was performed using specific primers and the ABI Prism 7000 analyser (Applied Biosystems) with the SYBR GreenER qPCR Super Mix Universal kit (Life Technologies). Target gene expression values were normalized to human GAPDH or mouse Gapdh. The primers used for qPCR were summarized in Supplementary Table 4 . Single-cell intracellular Ca 2+ measurements. Intracellular [Ca 2+ ] was measured with Fura-2 AM as previously described [35] [36] [37] [38] . In brief, HEK293 WT or STIM1-YFP/ORAI1-CFP stable cells were seeded and cultured on coverslips at least one day before imaging. To load Fura-2 AM, HEK293 cells were first kept in the imaging solution with 1 mM CaCl 2 and 2 µM Fura-2 AM for 30 min. Next, cells were kept in Fura-2 AM-free imaging solution with 1 mM CaCl 2 for another 30 min. For cells transfected with STIMATE that has constitutive Ca 2+ influx, 300 µM Ca 2+ or nominally Ca 2+ -free solution was used to keep cells healthy. Emission fluorescence at 509 nm generated by 340-nm excitation light (F 340 ) and 380-nm light (F 380 ) was collected every two seconds, and intracellular Ca 2+ levels are shown as the F 340 /F 380 ratio. After careful calibration, the Fura-2 intensities were further converted to Ca 2+ concentrations as we routinely did in previous studies 35, 37, 39 . All experiments were carried out at room temperature. Traces shown are representative of at least three independent repeats with each including 15-60 single cells.
Fluorescence resonance energy transfer measurements.
The same system used in Ca 2+ measurements plus an Optosplit II Image Splitter (Cairn Research Limited) was used for FRET measurements. CFP (428.9 ± 5.5 Ex / 465 ± 32 Em ), YFP (502.6 ± 11.2 Ex / 549 ± 21 Em ), FRET raw (428.9 ± 5.5 Ex / 549 ± 21 Em ) filters were used to capture raw images (F CFP F YFP and F raw , respectively) every 10 s at room temperature. To generate apparent FRET efficiency, E app , the following calculations on raw images were performed. First, three-channel-corrected FRET was calculated using the following formula: 40 . A fluorescence probe, YFP-STIM1-D76G-CFP, was expressed in HEK293 cells to examine the relative expression level of CFP-tagged protein to YFP-tagged ones. This construct was used as a negative control in our FRET experiments because the donor (CFP) and the acceptor (YFP) were separated by ER membrane with a distance of >10 nm (ref. 1). To minimize fluctuations in E app caused by variations of relative expression levels of donor protein to acceptor protein, only cells with a F CFP /F YFP ratio falling between 0.7 ∼ 1.4 were used for data analysis. All fluorescence images were collected and processed with MetaFluor software (Molecular Devices), and the resulting data were further analysed with Matlab R2012b software and plotted with Prism5 software. Representative traces of at least three independent experiments are shown as mean ± s.e.m.
NFAT-dependent luciferase assay. HEK293 cells were cultured in DMEM as described above in 24-well plates. After reaching 40-50% confluence, siRNA oligonucleotides were transfected using DharmaFECT (GE Dharmacon) for 48 h before further transfection of NFAT-luciferase reporter gene pGL4.30[luc2P/NFAT-RE/Hygro] (Promega). The Renilla luciferase gene (pRL-TK) was co-transfected as a control for counting transfected cells and normalizing the luminescence signals. HEK293 cells were treated with phorbol 12-myristate 13-acetate (PMA; 1 µM) and thapsigargin (1 µM) for 8 h. Three duplicates were used for each treatment. Cells were then collected and lysed by following the manufacturer's protocol. Luciferase activity was assayed using the Dual Luciferase Reporter Assay System (Promega) on a Biotek Synergy2 luminescence microplate reader. The ratio of firefly to Renilla luciferase activity was plotted for HEK293 cells. All of the data were normalized against the control group. For the rescue group, after 48 h treatment with siRNA, HEK293 cells were further transfected with the STIMATE-siRNA-resistant variant of mCherry-STIMATE, along with the NFAT-luciferase reporter genes and pRL-TK.
DSS-mediated crosslinking in HEK293 cells. HEK293 cells were plated in 6-
well plates and maintained at 37 • C and 5% CO 2 for 24 h before transfection. After transient transfection with FLAG-tagged STIMATE, cells were washed three times with ice-cold PBS (pH 8.0) and treated with 0, 50, 100 and 250 µM of freshly prepared DSS. The mixture was incubated on ice for 1-5 min and the reaction was stopped by incubating the cells with a quenching solution containing 50 mM Tris-HCl at pH 8.0 for 15 min at room temperature. The cells were then lysed by lysis buffer (20 mM HEPES pH 7.4, 150 NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate and 1 mM β-glycerophosphate), mixed with an equal volume of 2× sample loading buffer, heated at 42 • C for 10 min (to avoid aggregation), and subjected to electrophoresis on 4-12% precast gel (Bio-Rad). After transferring the lysates to the polyvinylidene fluoride (PVDF) membrane, it was immunoblotted with a monoclonal mouse anti-FLAG M2 antibody (1:3,000, Sigma).
Confocal imaging and total internal reflection fluorescence (TIRF) microscopy. Cell lines used for imaging include HEK293, HeLa and COS-7 cells cultured on 35-mm glass-bottom dishes (MatTek) at 37 • C with 5% CO 2 . All cells were grown in Dulbecco's modified Eagle's medium (DMEM, Sigma) supplemented with 10 mM HEPES, 100 units ml −1 penicillin, 100 µg ml −1 streptomycin and 10% heat-inactivated fetal bovine serum, unless otherwise noted. Confocal imaging was performed as previously described 32 . TIRF images were acquired on a NIKON Eclipse Ti-E microscope customized with Nikon A1R+ confocal laser sources with a ×60, NA 1.49 oil-immersion TIRF objective (Nikon). A 488-nm laser was used to excite GFP, and a 561-nm laser to excite mCherry. For two-colour imaging, 100-nm fluorescent beads (TetraSpecK Microspheres, Life Technologies) were deposited onto a coverslip and imaged as markers for later alignment.
To monitor LiMETER accumulation at ER-PM junctions, 50 ng LiMETER was transfected into normal or STIMATE-KO HEK293 cells using Lipofectamine 3000 (Life Technologies). Confocal images were acquired by using the Nikon A1R+ confocal laser sources. Images representative of the dark state of LiMETER (Fig. 4b with relatively low resolution) were acquired within 1 s using the fast scanning mode to minimize photoactivation of LiMETER by the 488-nm light source. TIRF timelapse imaging of LiMETER was performed 24-36 h post-transfection. The 488-nm laser source used to acquire the GFP signal of LiMETER was applied to activate the photoswitch LOV2. The images were acquired every 5 s for 5 min as one cycle. The cells were then kept in the dark for 5-10 min, followed by subsequent cycles of photostimulation.
Electron microscopy. Normal or STIMATE-KO HEK293 cells were plated onto poly-L-lysine-coated chamber slides for electron microscopy. After transient transfection with HRP-STIM1, the cells were treated with or without 1-2 µm thapsigargin for 5 min in Ca 2+ -and serum-free medium. The samples were washed with PBS twice and fixed using 2% glutaraldehyde in 0.1 M sodium cacodylate at room temperature for 1 h, then quickly moved to ice and washed with 0.1 M sodium cacodylate buffer for 10 min. HRP was visualized with 0.5 mg ml −1 diaminobenzidine and 0.03% hydrogen peroxide in 0.1 M sodium cacodylate buffer. Development of HRP took between 5 min and 20 min and was stopped by extensive washes with cold 0.1 M sodium cacodylate buffer. Cells were postfixed in 2% OsO 4 in 0.1 M cacodylate buffer (Electron Microscopy Sciences) at 4 • C for 1 h, washed in 0.1 M sodium cacodylate buffer and then contrasted in 2% aqueous uranyl acetate (Electron Microscopy Sciences) overnight at 4 • C, dehydrated in ethanol and embedded in epon for conventional electron microscopy. Images were acquired on a Morgagni transmission electron microscope (FEI) from Electron Microscopy Services provided by the Image Analysis Lab at Texas A&M University.
Image analyses. All acquired images were analysed using the NIKON NIS-Elements AR package or the ImageJ (NIH) software. The size of GFP-STIM1 puncta shown in Fig. 3b was quantified using ImageJ. Regions of interest (ROIs) within the images were determined using a manually selected pixel intensity threshold and the total pixel number per ROI was determined as a measure of puncta size. Using the same image analysis strategy, HRP-STIM1 relative distribution in ER was determined by measuring the total length of HRP-positive STIM1 segments and the length of multiple HRP-positive STIM1 segments migrated into cortical ER (separated within 20 nm from the PM). The Pearson correlation coefficient between EGFP-STIM1 and mCherry-STIMATE was calculated using the built-in co-localization analysis module of the NIS-Elements AR software. To determine the amount of MAPPER or LiMETER accumulation at cER and STIM1 puncta at ER-PM junctions, the TIRF images were background subtracted and converted to binary images to identify dim puncta and define the edges on the basis of optimized thresholds using the NISElements AR software (Nikon).
Pulldown and coimmunoprecipitation experiments. Expression and purification of recombinant proteins, as well as GST pulldown assays, were carried out as we described previously 31, 32, 35 . Bound proteins were visualized on SDS-PAGE after Coomassie brilliant blue R-250 staining. For coimmunoprecipitation experiments, transfected HEK293 cells were washed in cold PBS 3 times and lysed directly using lysis buffer including 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate and 1 mM β-glycerophosphate, supplemented with protease inhibitor cocktail and phosphatase inhibitor cocktail (Sigma), for 30 min at 4 • C. The lysates were clarified by centrifugation at 20,000g at 4 • C for 15 min. Equivalent sample amounts were subjected to SDS-PAGE, followed by transferring to PVDF membranes and probing with the appropriate primary and HRP-conjugated secondary antibodies. For immunoprecipitation, the cell lysates were incubated with the indicated antibodies and magnetic A or G beads (Thermo Scientific) overnight at 4 • C. The beads were pelleted and washed with lysis buffer, in the presence of protease inhibitors 10 times and were then heated in SDS loading buffer for 10 min at 42 • C before resolving on SDS-PAGE. The cell lysates were separated by 4-15% gels (Bio-Rad), transferred to PVDF membranes and probed with the indicated antibodies.
BIAcore surface plasmon resonance (SPR) measurements. SPR-based Biacore experiments were performed at 25 • C on a Biacore 3000 instrument (GE Healthcare Bio-Sciences AB). The immobilized STIM1-CC1 sensor surface was prepared by ligand thiol coupling through the single cysteine residue at the N terminus of CGG-CC1 (ref. 31) . The sensor chip CM3 and reagents for thiol coupling were purchased from GE Healthcare. The immobilization was performed at a 5 µl min −1 flow rate with PBS (10 mM sodium phosphate pH 7.4, 150 mM NaCl). The flow cell was activated by 0.4 M 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and 0.1 M N -hydroxysuccinimide followed by washing with 80 mM of 2-(2-pyridinyldithio)ethylamine hydrochloride (GE Healthcare) in 0.1 M sodium borate (pH 8.5) to introduce reactive disulphide groups on the surface. Thirty microlitres of STIM1-CC1 (10 µg ml −1 in 10 mM sodium acetate pH 5.5) was injected to the activated surface and then blocked with 20 µl of cysteine/NaCl. Approximately 550 RU (response unit) of STIM1-CC1 was immobilized. A reference flow cell was prepared with the same activation and blocking steps but without any protein coupled. The binding study was performed at 50 µl min −1 flow rate using TBS (20 mM Tris, 150 mM NaCl, pH 7.5) as running buffer. After each injection of STIMATE-CT (twofold serial dilution in running buffer), the CC1 surface was regenerated by injecting 10 mM glycine (pH 1.7) for 30 s to remove bound STIMATE-CT. Background-corrected sensorgrams were collected for data analysis.
Statistical analyses.
Unless otherwise noted, quantitative data are expressed as the mean and standard error of the mean (s.e.m.). Statistical significance was determined with paired Student's t-test. * P < 0.05; * * P < 0.01; * * * P < 0.001, when compared with control or WT.
